$LCTX
Lineage Cell Therapeutics, Inc.
XASE•Health Care•Biological Products, (No Diagnostic Substances)
$1.03
▲+0.00%+$0.000
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateLineage Cell Therapeutics, Inc.
XASE•Health Care•Biological Products, (No Diagnostic Substances)
Why is LCTX up today? It is at $1.03 (+0.00%), and our scanner flagged it 40 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment LCTX spikes, and full due diligence on LCTX — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $LCTX 40 times in the last 30 days. Create a free account to track $LCTX, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on LCTX from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for LCTX today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
Latest filing10-QQuarterly report (10-Q)Aug 6, 2026 · 45 days ago| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Culley Brian M Officer | Bought (open market) | +15K | added 6.2% | 256K | $24K at $1.62 | Mar 12, 26 |
Culley Brian M Officer | Sold (automatic/other) | -13K | sold 5.1% | 241K | $23K at $1.80 | Feb 11, 26 |
Culley Brian M Officer | Other | 31K 0.01% of company | added 14% | 253K | n/a | Feb 11, 26 |
Samuel George A. Iii Officer | Sold (automatic/other) | -3K | sold 7.5% | 31K | $5K at $1.80 | Feb 11, 26 |
Samuel George A. Iii Officer | Other | 6K | added 22% | 34K | n/a | Feb 11, 26 |
Samuel George A. Iii Officer | Acquired (grant/award) | +2K | added 6.7% | 28K | n/a | Dec 19, 25 |
Samuel George A. Iii Officer | Sold (automatic/other) | -65 | sold 0.2% | 27K | $109 at $1.68 | Dec 19, 25 |
Culley Brian M Officer | Acquired (grant/award) | +9K | added 4.2% | 222K | n/a | Dec 19, 25 |
Culley Brian M Officer | Sold (automatic/other) | -334 | sold 0.2% | 222K | $561 at $1.68 | Dec 19, 25 |
Culley Brian M Officer | Sold (automatic/other) | -13K | sold 5.5% | 214K | $8K at $0.650 | Feb 11, 25 |
Culley Brian M Officer | Other | 31K 0.01% of company | added 16% | 226K | n/a | Feb 11, 25 |
Samuel George A. Iii Officer | Sold (automatic/other) | -2K | sold 8.6% | 26K | $2K at $0.650 | Feb 11, 25 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Comparable names in biological products, (no diagnostic substances), closest in size first.
Here is the latest on LCTX from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for LCTX today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
LCTX last traded at $1.03, up 0.00% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Lineage Cell Therapeutics, Inc. (LCTX) is next expected to report earnings on Thursday, November 5, 2026, about 46 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The LCTX Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged LCTX 40 times in the last 30 days.
LCTX (Lineage Cell Therapeutics, Inc.) trades on XASE, with a market cap of about $260M in the Biological Products, (No Diagnostic Substances) sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge LCTX for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$LCTX discussion
Sign in to ask a question or join the discussion.